Prognostic Role of BRAF Mutation in Stage II/III Colorectal Cancer Receiving Curative Resection and Adjuvant Chemotherapy: A Meta-Analysis Based on Randomized Clinical Trials.
about
The relationship between diabetes and colorectal cancer prognosis: A meta-analysis based on the cohort studiesPrognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study.Current and future biomarkers in the treatment of colorectal cancer.Progression inference for somatic mutations in cancer.Prognostic value of the combination of microsatellite instability and mutation in colorectal cancerReport from the 19th annual Western Canadian Gastrointestinal Cancer Consensus Conference; Winnipeg, Manitoba; 29-30 September 2017
P2860
Prognostic Role of BRAF Mutation in Stage II/III Colorectal Cancer Receiving Curative Resection and Adjuvant Chemotherapy: A Meta-Analysis Based on Randomized Clinical Trials.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Prognostic Role of BRAF Mutati ...... on Randomized Clinical Trials.
@ast
Prognostic Role of BRAF Mutati ...... on Randomized Clinical Trials.
@en
type
label
Prognostic Role of BRAF Mutati ...... on Randomized Clinical Trials.
@ast
Prognostic Role of BRAF Mutati ...... on Randomized Clinical Trials.
@en
prefLabel
Prognostic Role of BRAF Mutati ...... on Randomized Clinical Trials.
@ast
Prognostic Role of BRAF Mutati ...... on Randomized Clinical Trials.
@en
P2093
P2860
P1433
P1476
Prognostic Role of BRAF Mutati ...... on Randomized Clinical Trials.
@en
P2093
Caixia Dong
Chenhan Zhong
Lizhen Zhu
Xuefeng Fang
P2860
P304
P356
10.1371/JOURNAL.PONE.0154795
P407
P577
2016-05-03T00:00:00Z